|
|
|
|
|
by dontmindifido
4357 days ago
|
|
I'd love to see them take an altruistic approach and shift the focus to countries like Africa where health projects would provide a lot more utility and have a lot less regulatory burden. Once a product is visibly working in one country it's more difficult to make cases against it elsewhere. |
|
I've worked with people involved in HIV vaccine trials overseas and, in fact, things really don't change as much as you might think.
The basic tenant "first do no harm" is ingrained at an many different ethical, institutional and legal levels that it isn't like you can, say, justify a more risky vaccine in an area with a higher risk for HIV or whatever.
In fact trials have been cut short and research into entire vectors (ie the cold virus used as a transport for the HIV related material) cut off when trials in Africa started to appear (statistically) to be slightly harmful in any way.
I feel this is a good thing. Scientists and medical people holding themselves to this high standard is the reason the anti-vaccine crowd really doesn't have a leg to stand on.